Arbutus Biopharma ABUS
NASDAQ ABUS
$4.69 -0.17 (-3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Total Current Liabilities (2010 - 2026)

Updated

Arbutus Biopharma (ABUS) posted Total Current Liabilities of $3.36 million for Q2 2026, down 33.0% from $5.02 million a year earlier and down 34.1% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Arbutus Biopharma's Total Current Liabilities came in at $6.01 million, down 61.5% from FY2024.

  • Annual Total Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -8.8% (FY2020 to FY2025).
  • In prior years, Arbutus Biopharma's Total Current Liabilities was $15.62 million in FY2024 (-30.5%), $22.49 million in FY2023 (-31.6%), $32.86 million in FY2022 (+192.8%) and $11.22 million in FY2021 (+17.6%).
  • The Q2 2026 figure stands as the lowest quarterly Total Current Liabilities in data going back to Q4 2010.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last 14 quarters, with an average decline of 46.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2022, with growth of 384.2%; the weakest was Q2 2025, with a decline of 77.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $5.11 million (Q1 2026), $6.01 million (Q4 2025) and $5.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Arbutus Biopharma 960.50 Mn 587.48 Mn - 3.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.36 Mn
Mar 31, 2026 5.11 Mn
Dec 31, 2025 6.01 Mn
Sep 30, 2025 5.18 Mn
Jun 30, 2025 5.02 Mn
Mar 31, 2025 19.43 Mn
Dec 31, 2024 15.62 Mn
Sep 30, 2024 18.92 Mn
Jun 30, 2024 22.60 Mn
Mar 31, 2024 20.30 Mn
Dec 31, 2023 22.49 Mn
Sep 30, 2023 22.32 Mn
Jun 30, 2023 24.53 Mn
Mar 31, 2023 25.15 Mn
Dec 31, 2022 32.86 Mn
Sep 30, 2022 27.51 Mn
Jun 30, 2022 29.82 Mn
Mar 31, 2022 32.41 Mn
Dec 31, 2021 11.22 Mn
Sep 30, 2021 10.11 Mn
API Access

Arbutus Biopharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABUS&period=max&api_key=YOUR_API_KEY